Urolithin A Reduces Noise-Induced Hearing Damage in Mice
Urolithin A reduced hearing damage in noise-exposed mice and increased mitochondrial cleanup markers. Human benefits remain unproven.
Summary
Urolithin A, a compound studied for helping cells clear damaged energy generators, reduced hearing damage in mice exposed to loud noise. Researchers gave young mice injections before and after a two-hour noise exposure, then measured hearing and examined inner ear tissue. Treated mice had smaller hearing changes than mice given saline, suggesting less damage. They also showed increased signs of mitochondrial cleanup and restored levels of a molecule that supplies cellular energy. The findings suggest a possible strategy for protecting hearing, an important part of maintaining independence and quality of life. However, this was an animal experiment, not a human supplement trial. The abstract does not provide the size of the hearing benefit or establish that mitochondrial cleanup caused it. Hearing protection remains essential.
Detailed Summary
Noise exposure can permanently damage hearing and disrupt mitochondria, the energy generators inside cells. Preserving hearing supports communication, independence, and quality of life. Researchers tested whether urolithin A, a compound studied for its effects on mitochondrial maintenance, could reduce hearing damage after loud noise in mice.
The study used eight-week-old CBA/J mice divided into three groups: an unexposed control group, a noise-exposed group given saline, and a noise-exposed group given urolithin A. Animals received the compound by abdominal injection at 10 mg/kg before and after two hours of broadband noise at 100 decibels. Researchers measured hearing using electrical responses from the auditory pathway and examined inner ear tissue.
Treated mice had significantly smaller increases in hearing thresholds than noise-exposed mice given saline, indicating less hearing impairment. Their inner ears also showed higher levels of PINK1, Parkin, and BNIP3, proteins or genes associated with clearing damaged mitochondria. Treatment restored ATP, a molecule cells use for energy, following noise exposure. Microscopy revealed more structures associated with mitochondrial cleanup in sensory and nerve regions of the cochlea.
These findings connect a potentially protective hearing effect with improved mitochondrial maintenance. However, increased cleanup markers do not establish that this process caused the hearing benefit. The work supports further research into urolithin A as a candidate intervention for noise-related injury, not a proven supplement strategy for humans.
This summary is based on the abstract only. The abstract does not report sample size, sex, randomization, blinding, numerical hearing benefits, or long-term outcomes. Young mice exposed to an acute noise challenge do not model all aspects of human hearing loss or aging. Injected dosing also cannot establish whether oral supplements would work. Human trials are needed before making treatment recommendations, and hearing protection remains the practical priority for anyone exposed to loud occupational or recreational sound levels.
Key Findings
- Injected urolithin A at 10 mg/kg reduced hearing threshold shifts after loud noise exposure in young mice.
- Treatment increased cochlear PINK1, Parkin, and BNIP3 markers associated with mitochondrial cleanup.
- Urolithin A restored ATP levels after noise exposure, suggesting better preservation of cellular energy supply.
- These animal findings do not establish that oral urolithin A supplements prevent hearing loss in humans.
Methodology
Eight-week-old CBA/J mice were divided into control, noise plus saline, and noise plus urolithin A groups. Urolithin A was injected intraperitoneally at 10 mg/kg before and after broadband noise exposure at 100 dB SPL for two hours. Assessments included auditory brainstem responses, protein and gene measurements, mitochondrial DNA integrity analysis, ATP measurements, and tissue imaging.
Study Limitations
This summary is based on the abstract only, which omits sample size, sex, randomization, blinding, numerical effect sizes, and follow-up duration. Young mice receiving injections around an acute noise exposure do not establish efficacy, safety, or oral dosing for humans or age-related hearing loss. Increased mitophagy-associated markers do not prove that mitochondrial cleanup caused the hearing benefit.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: